共 50 条
- [41] CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients European Journal of Clinical Pharmacology, 2018, 74 : 723 - 729
- [47] Protease inhibitors and diltiazem increase tacrolimus blood concentration in a patient with renal transplantation: a case report European Journal of Clinical Pharmacology, 2004, 60 : 603 - 605
- [50] Treatment with Erlotinib after Gefitinib Induced Hepatotoxicity: Literature Review and Case Report THERAPIE, 2014, 69 (02): : 163 - 168